Skip to main content
NA

NanoSpot.ai

NanoSpot.ai offers a point-of-care and home testing platform that utilizes agglutination techniques combined with artificial intelligence for accurate test interpretation. This technology enables rapid and reliable diagnostics, improving access to healthcare for patients outside traditional clinical settings.

Salt Lake City, United StatesFounded 20222200+ followers
Updated 4 months ago

Funding

$620K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Traditional diagnostic testing often requires specialized laboratory equipment and trained personnel, limiting accessibility and increasing turnaround times, especially in point-of-care or home settings. Accurate interpretation of test results can also be subjective and prone to human error.

Solution

NanoSpot.ai develops a point-of-care and home testing platform that combines agglutination techniques with artificial intelligence for rapid and accurate test interpretation. The platform utilizes a novel approach to visually detect and quantify the presence of specific biomarkers through agglutination, which is then analyzed by AI algorithms to provide objective and reliable results. This technology enables faster diagnosis and monitoring of various health conditions outside traditional clinical settings, improving access to healthcare and enabling timely interventions. The AI-powered analysis reduces subjectivity and enhances the accuracy of test interpretation, leading to better patient outcomes.

Target Audience

The primary target audience includes healthcare providers seeking rapid point-of-care diagnostics, individuals requiring convenient home testing solutions, and researchers developing novel diagnostic assays.

Features

  • Point-of-care and home testing platform for rapid diagnostics
  • Agglutination-based detection of target biomarkers
  • AI-powered image analysis for objective test interpretation
  • Cloud connectivity for data storage and remote monitoring
  • User-friendly interface for easy operation by non-experts
This profile is AI-generated and may contain inaccuracies.